硫酸软骨素市场规模、份额和成长分析（按来源、形式、应用和地区）- 2025-2032 年产业预测

Chondroitin Sulfate Market Size, Share, and Growth Analysis, By Source (Bovine, Swine), By Form (Powder, Tablet), By Application, By Region - Industry Forecast 2025-2032

出版日期: 2025年01月28日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2023 年硫酸软骨素市场规模价值 12.3 亿美元，预计将从 2024 年的 12.8 亿美元成长到 2032 年的 17.4 亿美元，预测期内（2025-2032 年）的复合年增长率为 3.9%。

硫酸软骨素的需求正在激增，这主要是由于膳食补充剂的日益普及和骨关节炎发病率的上升。药用级硫酸软骨素的需求预计将会成长，因为它主要用于治疗尿道结石、白内障、骨关节炎等。这种化合物富含葡萄糖醛酸和N-乙酰半乳醣胺，可增强关节功能，也可应用于兽医和眼科。肉品消费量的增加和宠物产业的蓬勃发展将进一步推动市场成长，因为动物器官对于硫酸软骨素的生产至关重要。骨关节炎是老年人的常见疾病，尤其是在新兴国家，而硫酸软骨素减轻发炎和提高运动表现的能力表明该领域前景光明，提供了巨大的市场机会。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲国家
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前 5 家公司对比
主要企业市场定位（2024年）
主要市场参与者所采用的策略
近期市场趋势
公司市场占有率分析（2024 年）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分析市场份额
- 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

TSI Group Co., LTD（China）
Qingdao Wan Toulmin Biological Sources Co., Ltd.（China）
Hebei Sanxin Industry Group Co., Ltd.（China）
Bioiberica SAU（Spain）
Sigma-Aldrich, Inc.（Merck KGaA, Germany）
ZPD A/S（Denmark）
Sino Siam Biotechnique Company Ltd.（Thailand）
BRF SA（Brazil）
Bio-gen Extracts Pvt. Ltd.（India）
Seikagaku Corporation（Japan）
Yantai Dongcheng Pharmaceutical Group Co., Ltd.（China）
Shandong Haiyu Biological Co., Ltd.（China）
Jiaxing Hengjie Biopharmaceutical Co., Ltd.（China）
Lianyungang Zhonghai Biological Technology Co., Ltd.（China）
Yantai Ruikangda Biochemical Products Co., Ltd.（China）
Shandong Topscience Biotech Co., Ltd.（China）
Titan Biotech Ltd.（India）
Fido Pharma Pvt. Ltd.（India）
Velnex Medicare（India）
TSI Group Ltd.（United States）

结论和建议

简介目录

Product Code: SQMIG15E2266

Chondroitin Sulfate Market size was valued at USD 1.23 billion in 2023 and is poised to grow from USD 1.28 billion in 2024 to USD 1.74 billion by 2032, growing at a CAGR of 3.9% during the forecast period (2025-2032).

The demand for chondroitin sulfate is surging, primarily driven by the increasing popularity of nutraceutical products and the rising prevalence of osteoarthritis. As pharmaceutical-grade chondroitin sulfate is predominantly used for treating conditions like UTI, cataracts, and osteoarthritis, its demand is set to expand. This compound, rich in glucuronic acid and N-acetylgalactosamine, enhances joint performance and has applications in veterinary medicine and eye care. The growing meat consumption and the burgeoning pet industry further fuel market growth, as animal parts are integral to chondroitin sulfate production. Osteoarthritis, a common ailment among the elderly, notably in developed countries, presents a significant market opportunity, with chondroitin sulfate offering relief from inflammation and improving mobility, indicating a robust outlook for this segment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Chondroitin Sulfate market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Chondroitin Sulfate Market Segments Analysis

Global Chondroitin Sulfate Market is segmented by Source, Form, Application and region. Based on Source, the market is segmented into Bovine, Swine, Poultry, Shark and Others. Based on Form, the market is segmented into Powder, Tablet and Others. Based on Application, the market is segmented into Pharmaceuticals andNutraceuticals, Animal Feed, Personal Care and Cosmetics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Chondroitin Sulfate Market

The increasing global population, particularly the aging demographic, is a key factor driving the growth of the chondroitin sulfate market. With older individuals more prone to joint-related disorders, such as osteoarthritis, the demand for effective treatments has risen. Chondroitin sulfate is widely recognized for its ability to alleviate pain, reduce inflammation, and enhance joint functionality, making it a preferred choice among healthcare providers and patients alike. This surge in age-related joint conditions has led to a heightened focus on therapies like chondroitin sulfate, thereby propelling its market and ensuring its significance in managing osteoarthritis and improving the quality of life for many.

Restraints in the Chondroitin Sulfate Market

The chondroitin sulfate market faces certain constraints due to the diverse regulatory standards and requirements established by various countries. Navigating these regulations can be intricate and labor-intensive, which poses significant challenges for new entrants aiming to establish themselves in the market. This complexity not only acts as a barrier to entry for potential competitors but also negatively influences overall market growth. As companies strive to meet these compliance demands, the process can consume valuable resources, ultimately hindering innovation and expansion within the chondroitin sulfate sector. Thus, regulatory challenges remain a critical restraint for the market's progress.

Market Trends of the Chondroitin Sulfate Market

The chondroitin sulfate market is witnessing a robust trend driven by the rising consumer inclination towards natural and organic ingredients in health supplements and nutraceuticals. As health-conscious consumers seek products with fewer artificial additives, the demand for chondroitin sulfate sourced from natural origins-such as bovine, porcine, and marine sources-has surged. This shift has prompted manufacturers to prioritize the development of high-quality chondroitin sulfate formulations that align with these preferences, leading to a proliferation of products marketed as organic or sustainably sourced. Consequently, this trend is expected to propel market growth, enhancing opportunities for innovation and diversification within the chondroitin sulfate segment.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Analysis
Patent Analysis

Global Chondroitin Sulfate Market Size by Source & CAGR (2025-2032)

Market Overview
Bovine
Swine
Poultry
Shark
Others

Global Chondroitin Sulfate Market Size by Form & CAGR (2025-2032)

Market Overview
Powder
Tablet
Others

Global Chondroitin Sulfate Market Size by Application & CAGR (2025-2032)

Market Overview
Pharmaceuticals and Nutraceuticals
Animal Feed
Personal Care and Cosmetics
Others

Global Chondroitin Sulfate Market Size & CAGR (2025-2032)

North America (Source, Form, Application)
- US
- Canada
Europe (Source, Form, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Source, Form, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Source, Form, Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Source, Form, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

TSI Group Co., LTD (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qingdao Wan Toulmin Biological Sources Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hebei Sanxin Industry Group Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioiberica S.A.U. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sigma-Aldrich, Inc. (Merck KGaA, Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZPD A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sino Siam Biotechnique Company Ltd. (Thailand)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BRF S.A. (Brazil)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-gen Extracts Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seikagaku Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Yantai Dongcheng Pharmaceutical Group Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shandong Haiyu Biological Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jiaxing Hengjie Biopharmaceutical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lianyungang Zhonghai Biological Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Yantai Ruikangda Biochemical Products Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shandong Topscience Biotech Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Titan Biotech Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fido Pharma Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Velnex Medicare (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TSI Group Ltd. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments